Financials
Income statement
Fiscal date | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 5.8B | 5.5B | 4.8B | 5.5B |
Cost of revenue | 3.9B | 4.0B | 3.0B | 3.5B |
Gross profit | — | 1.5B | 1.8B | 2.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 535M | 61M | 375M |
Operating income | — | 341M | 1.1B | 1.1B |
Non operating interest income | ||||
Income | — | 65M | -27M | 34M |
Expense | — | 451M | -140M | 154M |
Other income expense | — | — | — | — |
Pretax income | 774M | 786M | 690M | 447M |
Tax provision | — | 179M | 186M | 153M |
Net income | 583M | 607M | 504M | 294M |
Basic EPS | — | — | — | 0.3 |
Diluted EPS | — | — | — | 0.3 |
Basic average shares | — | — | — | 1.1B |
Diluted average shares | — | — | — | 1.1B |
EBITDA | — | 1.3B | 1.3B | 1.6B |
Net income from continuing op. | — | 786M | 690M | 447M |
Minority interests | -4M | -3M | 4M | -2M |
Preferred stock dividends | — | 0 | 0 | 0 |